| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.22 | 0.1 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.1 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.087 | 0.1 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |